疫情防控新闻发布会|上海向全国提供检测试剂盒360万人份

2020-03-06 马作宇 澎湃新闻

3月6日下午2:00,上海举行新闻发布会,邀请市卫生健康委新闻发言人郑锦、上海科创办执行副主任彭崧、市科委总工程师陆敏、市知识产权局副局长章永忠,介绍上海新冠肺炎疫情防控工作情况。市科委总工程师陆敏在发布会上介绍:疫情发生以来,上海市一大批科技型企业,聚焦疫情防控急需的新技术、新产品,快速响应,组织精兵强将,投入研发攻关、产品生产和防控应用,他们和医护工作者一样,始终战斗在一线,为打赢这场疫情防控

3月6日下午2:00,上海举行新闻发布会,邀请市卫生健康委新闻发言人郑锦、上海科创办执行副主任彭崧、市科委总工程师陆敏、市知识产权局副局长章永忠,介绍上海新冠肺炎疫情防控工作情况。

市科委总工程师陆敏在发布会上介绍:

疫情发生以来,上海市一大批科技型企业,聚焦疫情防控急需的新技术、新产品,快速响应,组织精兵强将,投入研发攻关、产品生产和防控应用,他们和医护工作者一样,始终战斗在一线,为打赢这场疫情防控总体战提供了有力的科技支撑。其中,在检测产品和药物研制方面,之江生物、伯杰医疗等3家企业快速研发出新冠病毒检测试剂盒,获得国家首批生产批件,目前已累积向全国各地提供检测试剂盒360多万人份,部分已出口海外。

此外,芯超生物、仁度生物等一批企业,已完成新一代检测产品的研制工作,已向国家药监局递交了申请材料;上药集团、斯微生物、君实生物、三优生物等企业持续推进疫苗和抗体药物研发,目前进展顺利;
 
新兴技术赋能疫情防控方面,一批新兴技术和产品率先应用到疫情防控第一线。其中,在医疗和智能设备方面,联影医疗累积向全国发出CT、DR等设备360余台,方舱CT已完成21台安装。达闼机器人提供的云端智能机器人,为武汉方舱医院、协和医院提供医疗护理、病区消毒和药品配送等服务;巨哥电子、深蓝科技等研发的红外测温监控系统在机场、高铁、地铁、楼宇实现规模化应用。

在人工智能技术应用方面,依图科技、商汤科技等推出一批医学影像筛查和基准测温产品,已在湖北一线医院、公卫中心等投入应用。在大数据技术应用方面,万达信息、网宿科技和优刻得等企业在相关数据资源免费发布和云服务方面为的疫情防控提供了强有力的支撑。

在5G技术应用方面,千寻位置、诺基亚贝尔为火神山、雷神山工地,提供了高精度测量和5G通信。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1991089, encodeId=6ea719910891b, content=<a href='/topic/show?id=69bd91e371a' target=_blank style='color:#2F92EE;'>#试剂盒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91737, encryptionId=69bd91e371a, topicName=试剂盒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Nov 25 03:45:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052632, encodeId=58fc2052632d6, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Aug 05 07:45:00 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992626, encodeId=005019926263d, content=<a href='/topic/show?id=b9f562561a1' target=_blank style='color:#2F92EE;'>#检测试剂盒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62561, encryptionId=b9f562561a1, topicName=检测试剂盒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Jul 03 05:45:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934654, encodeId=b9b11934654e0, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Dec 18 05:45:00 CST 2020, time=2020-12-18, status=1, ipAttribution=)]
    2020-11-25 tastas
  2. [GetPortalCommentsPageByObjectIdResponse(id=1991089, encodeId=6ea719910891b, content=<a href='/topic/show?id=69bd91e371a' target=_blank style='color:#2F92EE;'>#试剂盒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91737, encryptionId=69bd91e371a, topicName=试剂盒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Nov 25 03:45:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052632, encodeId=58fc2052632d6, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Aug 05 07:45:00 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992626, encodeId=005019926263d, content=<a href='/topic/show?id=b9f562561a1' target=_blank style='color:#2F92EE;'>#检测试剂盒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62561, encryptionId=b9f562561a1, topicName=检测试剂盒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Jul 03 05:45:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934654, encodeId=b9b11934654e0, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Dec 18 05:45:00 CST 2020, time=2020-12-18, status=1, ipAttribution=)]
    2020-08-05 宋威
  3. [GetPortalCommentsPageByObjectIdResponse(id=1991089, encodeId=6ea719910891b, content=<a href='/topic/show?id=69bd91e371a' target=_blank style='color:#2F92EE;'>#试剂盒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91737, encryptionId=69bd91e371a, topicName=试剂盒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Nov 25 03:45:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052632, encodeId=58fc2052632d6, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Aug 05 07:45:00 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992626, encodeId=005019926263d, content=<a href='/topic/show?id=b9f562561a1' target=_blank style='color:#2F92EE;'>#检测试剂盒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62561, encryptionId=b9f562561a1, topicName=检测试剂盒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Jul 03 05:45:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934654, encodeId=b9b11934654e0, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Dec 18 05:45:00 CST 2020, time=2020-12-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1991089, encodeId=6ea719910891b, content=<a href='/topic/show?id=69bd91e371a' target=_blank style='color:#2F92EE;'>#试剂盒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91737, encryptionId=69bd91e371a, topicName=试剂盒)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Wed Nov 25 03:45:00 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052632, encodeId=58fc2052632d6, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Wed Aug 05 07:45:00 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1992626, encodeId=005019926263d, content=<a href='/topic/show?id=b9f562561a1' target=_blank style='color:#2F92EE;'>#检测试剂盒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62561, encryptionId=b9f562561a1, topicName=检测试剂盒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Fri Jul 03 05:45:00 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934654, encodeId=b9b11934654e0, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Fri Dec 18 05:45:00 CST 2020, time=2020-12-18, status=1, ipAttribution=)]

相关资讯

站在最前面的战“疫”中医王檀

“他总是站在最前面的人。”队员们常常这样形容王檀,这位不爱说话却事事亲为的中医专家是医疗队里“定海神针”一样的存在。57岁的王檀是长春中医药大学附属医院肺病科主任,也是吉林省第二批支援武汉的中医医疗队队员。他的最新职务是“武汉雷神山医院C8病区主任”。“主任,患者蔡某,糖尿病病史,出现咳血……”“主任,患者吴某,心率130次/分……”病区里,突发情况时有发生,王檀常常是最忙碌的那个人,护目镜套着老

美国国会施压,前FDA局长或出任COVID-19工作组负责人!

尽管中国报告的新病例数量已趋于平稳,但随着更多其他国家报告病例增加,新型冠状病毒肺炎(COVID-19)疫情不容乐观。美国疾控中心警告,新冠病毒可能将在美国变得更加普遍。

罗氏追加捐赠共抗疫情,累计捐助总额超过2400万元

一方有难,八方支援。一场新冠疫情不仅让举国上下众志成城,也持续牵动着全体罗氏人的心。2020年2月24日到26日,在国务院应对新型冠状病毒肺炎疫情联防监控机制医疗救治组牵头协调下,罗氏制药中国已紧急通过中国初级卫生保健基金会先后两次捐赠总价值约1400万元人民币的托珠单抗注射液,以支持中国和武汉的医疗机构。一直以来,罗氏都以患者为先,争分夺秒地为患者带来生命希望。疫情爆发后,罗氏第一时间行动起来,

“战疫情,用笔尖凝聚爱”——主题征文活动开始啦!

“战疫情,用笔尖凝聚爱”——梅斯医学线上主题征文活动开始啦!

国家卫健委:低风险地区全面提供医疗服务!

经过多方共同努力,疫情形势发生积极变化,前期防控工作已取得初步成效,各地纷纷响应国家号召出台分区分级、精准施策的疫情防控措施。结合各地实际情况划分低、中、高风险区,并动态更新,为推动医疗服务回归正轨打下基础。

香港首现疑似新冠肺炎人传狗个案,医学专家:属偶发事件

日前,香港首次出现疑似新冠肺炎人传狗个案。一名确诊患者的狗只经反复测试,对病毒均呈弱阳性反应,低程度感染有关病毒。对此,有医学专家接受中新社记者访问时认为,人传动物的确“可能发生”,但属偶发事件,呼吁大众无需恐慌。香港特区政府渔农自然护理署(渔护署)发言人4日晚间确认,一只狗只在新冠肺炎病毒的反复测试中,对病毒均呈弱阳性反应,有关结果显示该狗只已低程度感染有关病毒,但它现时没有任何相关病征,正接受